Onyx Pharmaceuticals To Present At Merrill Lynch Global Pharmaceutical, Biotechnology And Medical Device Conference
EMERYVILLE, CALIF. — Jan. 31, 2006
Contact:
Julie Wood
510-597-6505
Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it will present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device conference on Tuesday, February 7, at 4:00 p.m. Eastern Time. Interested parties may access a live webcast of the presentation at:
http://www.wsw.com/webcast/ml53/onxx
It is recommended that listeners log on 15 minutes early in order to register and download any necessary software. For those unable to participate during the live webcast, a recorded replay of the presentation will be available within 24 hours of the completion of the presentation through March 7, 2006.
Onyx Pharmaceuticals is engaged in the development of novel cancer therapies that target the molecular basis of cancer. With its collaborators, the company is developing small molecule drugs, including Nexavar® (sorafenib) tablets with Bayer Pharmaceuticals Corporation. For more information about Onyx's pipeline and activities, visit the company's website at
www.onyx-pharm.com.
Nexavar® (sorafenib) tablets is a registered trademark of Bayer Pharmaceuticals Corporation.
Back to 2006 Press Releases
